With Biotech (XBI) down 2.3%, this looks like a sector-led move rather than a company-specific surprise.
The biotech sector, as measured by the XBI ETF, fell 2.31% due to broad market anxiety ahead of Federal Reserve Chair Kevin Warsh's speech at the Jackson Hole symposium. Investors are rotating out of growth-focused and high-risk sectors amid concerns that the Fed will signal a hawkish stance on interest rates. This risk-off sentiment is the primary driver of the downturn, overshadowing any company-specific news within the sector.